RayzeBio (NASDAQ:RYZB) Downgraded to “Market Perform” at William Blair
William Blair lowered shares of RayzeBio (NASDAQ:RYZB – Free Report) from an outperform rating to a market perform rating in a report released on Tuesday, MarketBeat Ratings reports. William Blair also issued estimates for RayzeBio’s FY2023 earnings at ($3.25) EPS, Q2 2024 earnings at ($0.06) EPS, Q3 2024 earnings at ($0.09) EPS, Q4 2024 earnings […]
More Stories
Rossby Financial LCC Invests $45,000 in Public Storage (NYSE:PSA)
Rossby Financial LCC acquired a new position in Public Storage (NYSE:PSA – Free Report) during the first quarter, according to...
Avrupa Minerals (CVE:AVU) Trading Up 20% – Here’s Why
Avrupa Minerals Ltd. (CVE:AVU – Get Free Report) was up 20% during trading on Friday . The stock traded as...
Voyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% – Here’s What Happened
Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) fell 11.5% during mid-day trading on Friday . The stock...
Oceanic Iron Ore (CVE:FEO) Stock Price Up 34% – What’s Next?
Oceanic Iron Ore Corp. (CVE:FEO – Get Free Report) rose 34% during mid-day trading on Friday . The stock traded...
Northern Dynasty Minerals (TSE:NDM) Trading 25% Higher – What’s Next?
Northern Dynasty Minerals Ltd. (TSE:NDM – Get Free Report) (NYSE:NAK)’s stock price traded up 25% on Friday . The stock...
Premier Health of America (CVE:PHA) Shares Down 15.4% – Here’s What Happened
Premier Health of America Inc. (CVE:PHA – Get Free Report) traded down 15.4% during mid-day trading on Friday . The...